The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised






About AngioScore

AngioScore designs, develops, manufactures and markets scoring balloon catheters to treat cardiovascular and peripheral artery diseases. It offers AngioSculpt RX, a rapid exchange coronary scoring device, and AngioSculpt PTCA, an over-the-wire scoring balloon catheter for the treatment of coronary arteries. The company also provides AngioSculpt PTA, a scoring balloon catheter for treating peripheral vascular diseases. Its products are used to treat dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra popliteal and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The company provides its products through direct sales in the United States, and through distributors in more than 60 countries.

AngioScore Headquarter Location

5055 Brandin Court

Fremont, California, 94538,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AngioScore

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AngioScore is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

AngioScore Patents

AngioScore has filed 35 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Vascular diseases
patents chart

Application Date

Grant Date


Related Topics




Cardiac anatomy, Cardiac surgery, Valvular heart disease, Cardiology, Congenital heart defects


Application Date


Grant Date



Related Topics

Cardiac anatomy, Cardiac surgery, Valvular heart disease, Cardiology, Congenital heart defects



Latest AngioScore News

Peripheral Vascular Devices Market Manufacturing Size, Share, Business Outlook, Vital Challenges and Forecast Analysis by 2031| Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation

Mar 30, 2021

| Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation Pune, Maharashtra, India, March 30 2021 (Wiredrelease) MarketResearch.Biz –:The New Report “Peripheral Vascular Devices Market” posted through MarketResearch.Biz, covers the market panorama and its growth possibilities over the upcoming years. The report also offers leading players in this market. The research comprises in-depth insight of the worldwide share, size, and developments, in addition to the growth rate of the Peripheral Vascular Devices Market to estimate its development throughout the forecast period. Most importantly, the report in addition identifies the historical, current, and future developments which might be predicted to persuade the improvement ratio of the Peripheral Vascular Devices market. The research segments the market on the premise of product type, end user, and region. To provide extra readability concerning the Peripheral Vascular Devices industry, the report takes a more in-depth study the contemporary fame of different factors along with however now no longer confined to deliver chain management, area of interest markets, distribution channel, trade, deliver, supply and manufacturing functionality regionwise. The Peripheral Vascular Devices market report has provided an evaluation of different factors influencing the market’s ongoing rise. Drivers, restraints, and Peripheral Vascular Devices market developments are elaborated to apprehend their tremendous or terrible effects. This segment is aimed toward supplying readers with thorough facts approximately the capability scope of diverse programs and segments. These Peripheral Vascular Devices market estimates are primarily based totally on the present developments and ancient milestones. Get a Free Sample Copy Of Peripheral Vascular Devices Market Research Report Here: *** NOTE: Our Free Complimentary Sample Report Offers a Brief Summary Of The Report, TOC, Company Profiles and Geographic Segmentation, List of Tables and Figures, and Future Estimation *** The top players Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien are examined through the following points: Company Profile Financial Analysis SWOT Analysis and Porter’s Five Forces Evaluation COVID – 19 Impact Analysis on Latest Peripheral Vascular Devices Market Situation (Drivers, Restraints, Trends, Challenges and Opportunities) Global Peripheral Vascular Devices market has been studied definitely to get higher insights into the businesses. Across the globe, various regions includes North America, Latin America, Asia-Pacific, Europe, and Africa were summarized withinside the report Peripheral Vascular Devices Market. Request Here For The Covid-19 Impact On Peripheral Vascular Devices Market: *** NOTE: MarketResearch.Biz crew are reading Covid19 updates and its effect at the increase of the Peripheral Vascular Devices market and wherein important we can take into account Covid-19 footmark for a higher evaluation of the market and industries. Contact us cogently for extra targeted facts. *** Peripheral Vascular Devices Market Segmentation: Global peripheral vascular devices market segmentation by product type: Balloon expanding stent (Device), Self-Expanding stent (Device), Drug eluting stent (Device), Bare metal stent (Device). Global peripheral vascular devices market segmentation by end user: Hospitals, Ambulatory surgical centres, Specialty clinics Global Peripheral Vascular Devices Market: Regional Analysis The Peripheral Vascular Devices market research report studies the contribution of diverse areas withinside the market through information on their political, technological, social, environmental, and financial fame. Peripheral Vascular Devices market analysts have covered reports referring to each location, its manufacturers, and revenue. The areas studied withinside the market consist of North America, Europe, Asia Pacific, South and Central America, South Asia, the Middle and Africa, South Korea, and others. This segment is targeted at supporting the Peripheral Vascular Devices market reader examine the capability of every location for making sound investments. Do You Have Any Query Or Specific Requirement? Drop Your Query Here: The Peripheral Vascular Devices market objective examine are: – Peripheral Vascular Devices Overview Market Status and Future Forecast 2021 to 2031 – Peripheral Vascular Devices Market report mentioned product developments, partnerships, mergers and acquisitions, R&D tasks are mentioned – Peripheral Vascular Devices Market Details on Opportunities and Challenges, Restrictions and Risks, Market Drivers, Challenges. – General aggressive scenario, along with the principle market players, their growth targets, expansions, deals. – In-depth Description of Peripheral Vascular Devices Market Manufacturers, Sales, Revenue, Market Share, and Latest Developments for Key Players. – To examine and research the Peripheral Vascular Devices market through product type, end user, and region The major questions replied withinside the report: – What are the principal elements that take this market to the top level? – What is the market growth and demand analysis? – What are the recent possibilities for the Peripheral Vascular Devices market withinside the coming period? – What are the principal benefits of the player? – What is the important thing to the Peripheral Vascular Devices market? Buy the Peripheral Vascular Devices  Market research report now @ Table of Contents: Section 1: Based on an executive synopsis of this report. And additionally, it consists of key developments of the Peripheral Vascular Devices market associated with products, applications, and different critical elements. It additionally affords an evaluation of the aggressive panorama and CAGR and market length of the Peripheral Vascular Devices market primarily based totally on manufacturing and revenue. Section 2: Production and Consumption Through Region: It covers all nearby markets to which the research examine relates. Prices and key players similarly to manufacturing and intake in every nearby Peripheral Vascular Devices market are mentioned. Section 3: Key Players: Here, the Peripheral Vascular Devices report throws mild on monetary ratios, pricing structure, manufacturing cost, gross profit, income volume, revenue, and gross margin of main and outstanding companies. Section 4: Market Segments: This part of the report discusses product kind and alertness segments of the Peripheral Vascular Devices market primarily based totally on market share, CAGR, market size, and diverse different elements. Section 5: Research Methodology: This segment discusses the research technique and technique used to put together the Peripheral Vascular Devices report. It covers reports triangulation, market breakdown, market length estimation, and research layout and/or programs. More Trending Reports:

  • When was AngioScore founded?

    AngioScore was founded in 2003.

  • Where is AngioScore's headquarters?

    AngioScore's headquarters is located at 5055 Brandin Court, Fremont.

  • What is AngioScore's latest funding round?

    AngioScore's latest funding round is Acquired.

  • How much did AngioScore raise?

    AngioScore raised a total of $87M.

  • Who are the investors of AngioScore?

    Investors of AngioScore include Spectranetics, California Technology Ventures, Psilos Group, Pelion Venture Partners, Telegraph Hill Partners and 12 more.

  • Who are AngioScore's competitors?

    Competitors of AngioScore include EyeTechCare, Xlumena, Tandem Diabetes Care, SpinalMotion, Advanced Biosurfaces and 11 more.

You May Also Like

NeoChord Logo

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

AlterG Logo

AlterG builds technology for physical rehabilitation, training and wellness with the goal of enabling people to sustain healthy and active lives through mobility. The company's products, the Anti-Gravity Treadmills and the AlterG Bionic Leg, are designed to enhance personal mobility and wellness. Its Anti-Gravity Treadmills use Differential Air Pressure (DAP) technology, originally developed at NASA, to unweight patients to as low as 20% of their body weight, enabling them to walk or run with reduced impact. The Bionic Leg, designed for patients with neurological and orthopedic gait disorders, is a robotic assistive device that is activated by patient initiated movement and provides stability and assistance for a full range of mobility training.


Coromedic is a privately owned biomedical start up company working to manufacture devices and develop techniques to facilitate coronary artery bypass surgery in a minimally invasive technique. The company's flagship products, the proximal anastomosis device, the distal anastomosis device and the internal mammary artery harvester are a in a set of invaluable tools aimed at easing the complications associated with the conventional surgery. The company have worked to design and build prototypes of the company's products and develop a business strategy, consulting with numerous professionals to assess the feasibility and utility of the company's product and business model. The process of idea protection and patent application is ongoing, a provisional patent for one of the company's products, the proximal anastomosis devices is in place and the application for patent protection of all the company's products is underway. The prototype of the company's first device, the proximal anastomosis device is built and tested in the wet lab. The company are currently working on prototype assembly of the company's second and third products, after which lab animal experiments in the appropriate facilities will take place and then approval for clinical trials and their undertaking will commence.

Angel Medical Systems Logo
Angel Medical Systems

Angel Medical Systems has developed the AngelMed Guardian system, an implantable cardiac monitoring and alerting system that is designed to warn cardiac patients of potentially life-threatening heart conditions. The AngelMed Guardian System heart monitor is designed to track changes in the heart's electrical signal from a standard pacemaker lead, identify the signature of acute thrombotic occlusions when they occur, and then alert the patient directly to seek medical attention. The device is being studied in high risk heart patients who do not qualify for an ICD, but who have had a STEMI, NSTEMI or unstable angina in their recent past.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.